中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共6条，第1-6条 帮助

条数/页： 排序方式：
Simultaneous determination of unecritinib (TQ-B3101) and its active metabolite crizotinib in rat plasma by LC-MS/MS:An application to pharmacokinetic studies 期刊论文  OAI收割
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 卷号: 246, 页码: 9
作者:  Wang, Hong;  Chen, Huixian;  Cui, Xinran;  Zhang, Yuchen;  Zhou, Jialan
  |  收藏  |  浏览/下载：16/0  |  提交时间：2024/07/12
A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib 期刊论文  OAI收割
CLINICAL LUNG CANCER, 2021, 卷号: 22
作者:  Chen, Kaiyan;  Zhang, Fanrong;  Pan, Guoqiang;  Sheng, Jiamin;  Ye, Junyi
  |  收藏  |  浏览/下载：56/0  |  提交时间：2021/03/15
Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3 期刊论文  OAI收割
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15
作者:  Selvaggi, G.;  Wakelee, H. A.;  Mok, T.;  Wu, Y. -L.;  Reck, M.
  |  收藏  |  浏览/下载：170/0  |  提交时间：2020/11/30
SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 7
作者:  Xia, Zong-jun;  Ji, Yin-chun;  Sun, De-qiao;  Peng, Xia;  Gao, Ying-lei
  |  收藏  |  浏览/下载：58/0  |  提交时间：2020/12/21
Pharmacologic characterization of CT-711, a novel dual inhibitor of ALK and c-Met 期刊论文  OAI收割
AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 卷号: 8, 期号: 8, 页码: 1541-1550
作者:  Wang, Lei;  Gao, Mingzhao;  Tong, Mengya;  Xie, Chengying;  He, Ye
  |  收藏  |  浏览/下载：155/0  |  提交时间：2019/01/08
Alectinib: a novel second generation anaplastic lymphoma kinase (ALK) inhibitor for overcoming clinically-acquired resistance 期刊论文  OAI收割
ACTA PHARMACEUTICA SINICA B, 2015, 卷号: 5, 期号: 1, 页码: 34-37
作者:  Song, Zilan;  Wang, Meining;  Zhang, Ao
  |  收藏  |  浏览/下载：67/0  |  提交时间：2019/01/08